Document is current
Any future updates will be listed below
-
Authors
Pfeiffer, Elisa https://orcid.org/0000-0002-9742-3004
Krech, Fabienne https://orcid.org/0009-0001-4320-8130
Allroggen, Marc
Schulze, Ulrike M.E.
Plener, Paul L. https://orcid.org/0000-0003-4333-1494
Braun, Uschi
Ercengiz, Deniz
Wollenek, Valentin
Heinrichs, Nina https://orcid.org/0000-0002-8301-5798
Möllmann, Anne https://orcid.org/0000-0003-0439-8258
-
Funding
Funding for this research was provided by:
Universität Ulm
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 10 March 2026
First Online: 24 March 2026
Declarations
:
: The study was approved by the Ethics Committee of Ulm University (Number: 307/22) and the Medical University Vienna (Number: 1147/2023). Written informed consent was obtained from all participants and, for those under the age of 16, from their legal guardians.
: Not applicable.
: PLP is an advisor for Boerhinger Ingelheim and receives speaker honoraria from GSK, Janssen, infectopharm, Consilium and Oral B. The other authors have no conflicts of interest to declare.
